N-(3-Bromo-1,4-dioxo-1,4-dihydro-2-naphth-yl)-2-chloro-N-(2-chloro-benzoyl)benzamide.

Acta Crystallogr Sect E Struct Rep Online

Department of Chemistry, Howard University, 525 College Street NW, Washington, DC 20059, USA.

Published: December 2008

The title compound, C(24)H(12)BrCl(2)NO(4), was synthesized from 2-amino-3-bromo-1,4-naphthoquinone and 2-chloro-benzoyl chloride. The crystal structure shows that each of the chloro-phenyl rings is inclined at about 60° to the naphthoquinone ring system. The two chloro-phenyl rings adopt a conformation that ensures that chlorine substituents are anti so as to reduce electronic repulsion. An examination of the packing shows close O⋯Br and Cl⋯Cl contacts of 2.947 (2) and 3.346 (1) Å, respectively. In addition, the molecules are linked by weak intermolecular C-H⋯O and C-H⋯Cl interactions.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2967943PMC
http://dx.doi.org/10.1107/S1600536808039214DOI Listing

Publication Analysis

Top Keywords

chloro-phenyl rings
8
n-3-bromo-14-dioxo-14-dihydro-2-naphth-yl-2-chloro-n-2-chloro-benzoylbenzamide title
4
title compound
4
compound c24h12brcl2no4
4
c24h12brcl2no4 synthesized
4
synthesized 2-amino-3-bromo-14-naphthoquinone
4
2-amino-3-bromo-14-naphthoquinone 2-chloro-benzoyl
4
2-chloro-benzoyl chloride
4
chloride crystal
4
crystal structure
4

Similar Publications

In the title compound, CHClNO, the seven-membered 1,4-diazepane ring adopts a chair conformation while the 4-chloro-phenyl substituents adopt equatorial orientations. The chloro-phenyl ring at position 7 is disordered over two positions [site occupancies 0.480 (16):0.

View Article and Find Full Text PDF

In the title compound, CHClNOS, the thia-zole ring subtends dihedral angles of 13.12 (14) and 43.79 (14) ° with the attached chloro-phenyl and phenyl rings, respectively.

View Article and Find Full Text PDF

Selective estrogen receptor modulators (SERMs) act as estrogen receptor (ERα) agonists or antagonists depending on the target issue. Tamoxifen (TAM) (a non-steroidal triphenylethylene derivative) was the first SERM approved as anti-estrogen for the treatment of metastatic breast cancer. On the hunt for novel SERMs with potential growth inhibitory activity on breast cancer cell lines yet no potential to induce endometrial carcinoma, we designed and synthesized 28 novel TAM analogs.

View Article and Find Full Text PDF

The mol-ecular conformation of the title compound, CHClNO, is stabilized by an intra-molecular O-H⋯O hydrogen bond, forming an (6) ring motif. The central pyridine ring is almost planar [maximum deviation = 0.074 (3) Å].

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!